Gigučre, Vincent <br/><br/>
DNA-PK, Nuclear mTOR, and the Androgen Pathway in Prostate Cancer.  [electronic resource] 

 -  Trends in cancer  04 2020 
 - 337-347 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>2405-8025 
<br/><br/><label>Standard No.: </label>10.1016/j.trecan.2020.01.015  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Androgens--metabolism<br/>Cell Line, Tumor<br/>Cell Nucleus--metabolism<br/>Chromatin--metabolism<br/>DNA-Activated Protein Kinase--antagonists & inhibitors<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Male<br/>Prostatic Neoplasms--drug therapy<br/>Protein Kinase Inhibitors--pharmacology<br/>Receptors, Androgen--metabolism<br/>Signal Transduction--drug effects<br/>TOR Serine-Threonine Kinases--antagonists & inhibitors<br/>Transcription Factors--antagonists & inhibitors<br/>Xenograft Model Antitumor Assays